Related Experiment Video
Updated: Apr 20, 2026
06:45
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
17.2K
Patient preferences regarding pharmacologic venous thromboembolism prophylaxis
Adrian Wong1, Peggy S Kraus, Brandyn D Lau
1Department of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland.
Journal of Hospital Medicine
|November 25, 2014
Summary
Most patients prefer oral medication for venous thromboembolism (VTE) prophylaxis due to needle aversion. Incorporating patient preferences for VTE prophylaxis may improve adherence and reduce VTE incidence.
Area of Science:
- Medical Research
- Patient Care
- Pharmacology
Background:
- Guidelines recommend considering patient preferences for venous thromboembolism (VTE) prophylaxis.
- Patient-centered care is crucial in VTE prevention strategies.
Purpose of the Study:
- To determine patient preferences for pharmacologic venous thromboembolism (VTE) prophylaxis.
- To understand the rationale behind patient preferences for VTE prophylaxis administration routes.
Main Methods:
- A single-center, mixed-methods survey was conducted.
- Consecutive hospitalized patients on surgical and medical units were included.
- Patient preferences for oral versus subcutaneous VTE prophylaxis and their reasons were analyzed.
Main Results:
- A majority of patients (60.4%) preferred oral VTE prophylaxis over subcutaneous options.
- Dislike of needles and injection pain were primary reasons for preferring oral agents.
- Patients preferring subcutaneous injections cited a presumed faster onset of action.
Conclusions:
- A majority of medical and surgical patients prefer oral VTE prophylaxis.
- Integrating patient preferences, particularly for oral agents, may enhance prophylaxis adherence.
- Considering patient preferences can improve VTE prophylaxis delivery and reduce VTE incidence.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
477
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
477
01:30Venous Thrombosis IV: Nursing Management
400
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
400
01:27Pulmonary Embolism III: Nursing Management
717
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
717
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
451
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
451
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K